Travere Therapeutics competitorsClear all

Genexine's top competitors include JCR Pharmaceuticals and Kamada Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Genexine
Genexine
Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics.
JCR Pharmaceuticals
JCR Pharmaceuticals
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
Kamada Pharmaceuticals
Kamada Pharmaceuticals
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Founding Date
Founding Date
1999
Founding Date
1975
Founding Date
1990
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seongnam-si, KR HQ
New York, US
Locations
Ashiya, JP HQ
Locations
Rehovot, IL HQ
Beit Kama, IL
Employees
Employees
102
Employees
732
Employees
35513% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.1 b
Valuation ($)
204.3 m
Alexa Website Rank
Alexa Website Rank
636431
Alexa Website Rank
650137
Alexa Website Rank
859663
Employee Rating
Employee Rating
N/A
Employee Rating
5
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
₩36.8b (FY, 2021)
Revenue (est.)
¥51.1b (FY, 2022)
Revenue (est.)
$103.6m (FY, 2021)
Cost of goods
Cost of goods
(₩2.1b) (FY, 2021)
Cost of goods
(¥8.5b) (FY, 2022)
Cost of goods
($52.8m) (FY, 2021)
Gross profit
Gross profit
₩36.6b (FY, 2021)
Gross profit
¥42.6b (FY, 2022)
Gross profit
$50.9m (FY, 2021)
Net income
Net income
(₩48.6b) (FY, 2021)
Net income
¥14.5b (FY, 2022)
Net income
($2.2m) (FY, 2021)
For sources of this data, please see the company profile

View company profiles

JCR Pharmaceuticals
HQ
Ashiya, JP
Employees
732

JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.

View company
Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
355↓ 13% decrease

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company